International Conference on HIV and Drug Resistance Studies - (ICHDRS-26)

About the event

*Latest developments in HIV treatment, prevention, and drug-resistance research. *Mechanisms and genetic pathways involved in HIV drug resistance. *Detection and interpretation of antiretroviral resistance mutations. *Genotypic and phenotypic drug-resistance testing and their clinical applications. *Management of virologic failure and treatment-experienced patients. *Strategies for selecting and optimizing antiretroviral therapy (ART) when resistance is detected. *Emerging resistance to newer antiretroviral classes, including integrase strand-transfer inhibitors (INSTIs). *The relationship between adherence, viral suppression, treatment failure, and resistance development. *HIV drug-resistance surveillance and molecular epidemiology. *Drug-resistance considerations associated with PrEP and long-acting HIV prevention. *Advances in viral-load monitoring, molecular diagnostics, and genomic technologies. *Strategies for strengthening HIV resistance testing and laboratory capacity, particularly in low- and middle-income settings. *Public-health strategies for preventing the emergence and transmission of drug-resistant HIV. *Current research, clinical case studies, and emerging approaches to HIV drug-resistance management. *Opportunities for international collaboration in HIV research, surveillance, prevention, and treatment.